神经源性外泌体通过miR-155-5p/SOX1/Wnt/β-catenin轴调控宫颈癌嗜神经侵袭的作用机制研究
批准号:
82103029
项目类别:
青年科学基金项目(C类)
资助金额:
30.0 万元
负责人:
范琼
依托单位:
学科分类:
基于特殊临床特征的肿瘤研究
结题年份:
2024
批准年份:
2021
项目状态:
已结题
项目参与者:
范琼
中文摘要
宫颈癌嗜神经侵袭可能给保留盆腔自主神经的广泛性子宫切除术带来盆底或盆腔复发的风险,因此厘清宫颈癌嗜神经侵袭的分子机制是目前宫颈癌个体化手术治疗所急需解决的问题。申请人前期研究发现,外周神经胶质细胞雪旺细胞来源的CCL2促进宫颈癌细胞增殖、迁移、侵袭和上皮间质转化,同时肿瘤细胞上调雪旺细胞基质金属蛋白酶表达促进基质溶解,雪旺细胞与宫颈癌细胞交互作用形成肿瘤神经微环境促进嗜神经侵袭(Front Oncol. 2020)。进一步研究发现,背跟神经节细胞培养上清促进宫颈癌细胞侵袭,背跟神经节细胞源性外泌体通过miR-155-5p/SOX1轴激活Wnt/β-catenin信号通路。本项目拟在前期研究基础上,阐述神经源性外泌体通过miR-155-5p/SOX1/Wnt/β-catenin轴调控宫颈癌细胞嗜神经侵袭分子机制,指导保留盆腔自主神经的广泛性子宫切除术患者筛查方案的建立奠定理伦基础。
英文摘要
Tumor perineural invasion (PNI) may bring high risk of pelvic floor or pelvic recurrence to the individualized extensive nerve sparing radical hysterectomy (NSRH). Therefore, it is crucial to clarify the molecular mechanism of PNI in the individualized surgery of cervical cancer. In our previous study, we found that CCL2 derived from peripheral Schwann cells promote the proliferation, migration, invasion and epithelial-mesenehymal transition of cervical cancer cells, while cancer cells could up-regulate the expression of Schwann cell matrix metalloproteinase to promote matrix dissolution, and Schwann cells interact with cervical cancer cells to form a tumor microenvironment to promote PNI (Front.Oncol. 2020). Further study showed that the supernatant of dorsal root ganglion (DRG) cells promoted the invasion of cervical cancer cells, and the exosomes of DRG cells activated Wnt/β-catenin signaling pathway through miR-155-5p/SOX1 axis. On the basis of our previous studies, this project intends to elaborate the molecular mechanism of neurogenic exosomes modulating the PNI of cervical cancer cells through miR-155-5p/SOX1/Wnt/β-catenin axis, thus providing experimental evidence for the establishment of clinical screening program for patients with extensive nerve sparing radical hysterectomy (NSRH) .
盆腔自主神经的保留对早期宫颈癌NSRH个体化手术治疗至关重要,但却碍于对肿瘤的嗜神经侵袭PNI无法识别。前期申请人研究发现施旺细胞通过CCL2作用于宫颈癌细胞形成肿瘤-神经互作的微环境现象;并注意到神经细胞的上清就可促进肿瘤侵袭。由此推测微环境中神经细胞可通过外泌体 “远程对话”传递信号来促进宫颈癌发生PNI。研究揭示了宫颈癌进展过程中PNI是晚期宫颈癌的特征,施旺细胞是启动PNI的先行细胞。此外,宫颈癌细胞产生的神经肽神经调节素 B (NMB) 被确定可通过重编程施旺细胞来诱导 PNI,包括驱动其形态和转录变化,促进其增殖和迁移,并通过分泌 CCL2 来启动 PNI。为临床联合NMB血清标志物指导NSRH个体化临床实践提供实验依据。
国内基金
海外基金